The increasing complexity of malignant diseases treatment necessitates a comprehensive understanding of varied healthcare approaches. This article aims to explore the benefits and limitations of transatlantic cancer care, comparing the clinical pathways in both the United States and the European Union. Through a systemic lens, we will examine key d